428
Participants
Start Date
January 19, 2024
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
AZD0780
AZD0780 administered orally, once daily for 12 weeks
Placebo
Placebo administered orally, once daily for 12 weeks
Research Site, Budapest
Research Site, Hvidovre
Research Site, Debrecen
Research Site, Svendborg
Research Site, Orosháza
Research Site, Herning
Research Site, Pécs
Research Site, Aarhus
Research Site, Viborg
Research Site, New Windsor
Research Site, Córdoba
Research Site, A Coruña
Research Site, Ferrol
Research Site, Santiago(A Coruña)
Research Site, Greensboro
Research Site, Jacksonville
Research Site, Hialeah
Research Site, Boca Raton
Research Site, Inverness
Research Site, Huntsville
Research Site, Louisville
Research Site, Seville
Research Site, Seville
Research Site, Seville
Research Site, Indianapolis
Research Site, Fargo
Research Site, Uherské Hradiště
Research Site, San Marcos
Research Site, Palm Springs
Research Site, Santa Ana
Research Site, Lincoln
Research Site, Barrie
Research Site, Brampton
Research Site, Cambridge
Research Site, Concord
Research Site, Guelph
Research Site, Toronto
Research Site, Benešov
Research Site, Brandýs nad Labem
Research Site, Brno
Research Site, Louny
Research Site, Náchod
Research Site, Prague
Research Site, Příbram
Research Site, Teplice
Research Site, Chūōku
Research Site, Itabashi-ku
Research Site, Bratislava
Research Site, Brezno
Research Site, Lučenec
Research Site, Prešov
Research Site, Rožňava
Research Site, Svidník
Research Site, Trebišov
Research Site, Barcelona
Lead Sponsor
AstraZeneca
INDUSTRY